Details der Publikation - Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Low-resolution figures were inadvertently created during production and published..

Medienart:	E-Artikel

Erscheinungsjahr:	2020
Erschienen:	2020

Enthalten in:	Zur Gesamtaufnahme - volume:100
Enthalten in:	Annals of hematology - 100(2020), 1 vom: 27. Okt., Seite 297-302

Sprache:	Englisch

Beteiligte Personen:	Kaiser, Martin [VerfasserIn] Beksaç, Meral [VerfasserIn] Gulbrandsen, Nina [VerfasserIn] Schjesvold, Fredrik [VerfasserIn] Hájek, Roman [VerfasserIn] Moreau, Philippe [VerfasserIn] de la Fuente, Felipe de Arriba [VerfasserIn] Mateos, María-Victoria [VerfasserIn] West, Sharon [VerfasserIn] Spencer, Andrew [VerfasserIn] Rajkumar, S. Vincent [VerfasserIn] Suryanarayan, Kaveri [VerfasserIn] Czorniak, Michael [VerfasserIn] Li, Cong [VerfasserIn] Teng, Zhaoyang [VerfasserIn] Labotka, Richard [VerfasserIn] Dimopoulos, Meletios A. [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

RVK:	RVK Klassifikation ELIB24

Anmerkungen:	© Springer-Verlag GmbH Germany, part of Springer Nature 2020

doi:	10.1007/s00277-020-04302-0

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC212236064X

Internformat


LEADER	01000naa a22002652 4500
001	OLC212236064X
003	DE-627
005	20230505062625.0
007	cr uuu---uuuuu
008	230505s2020 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s00277-020-04302-0 \|2 doi
035			\|a (DE-627)OLC212236064X
035			\|a (DE-He213)s00277-020-04302-0-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a ELIB24 \|q VZ \|2 rvk
100	1		\|a Kaiser, Martin \|e verfasserin \|4 aut
245	1	0	\|a Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma
264		1	\|c 2020
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Springer-Verlag GmbH Germany, part of Springer Nature 2020
520			\|a Low-resolution figures were inadvertently created during production and published.
700	1		\|a Beksaç, Meral \|4 aut
700	1		\|a Gulbrandsen, Nina \|4 aut
700	1		\|a Schjesvold, Fredrik \|4 aut
700	1		\|a Hájek, Roman \|4 aut
700	1		\|a Moreau, Philippe \|4 aut
700	1		\|a de la Fuente, Felipe de Arriba \|4 aut
700	1		\|a Mateos, María-Victoria \|4 aut
700	1		\|a West, Sharon \|4 aut
700	1		\|a Spencer, Andrew \|4 aut
700	1		\|a Rajkumar, S. Vincent \|4 aut
700	1		\|a Suryanarayan, Kaveri \|4 aut
700	1		\|a Czorniak, Michael \|4 aut
700	1		\|a Li, Cong \|4 aut
700	1		\|a Teng, Zhaoyang \|4 aut
700	1		\|a Labotka, Richard \|4 aut
700	1		\|a Dimopoulos, Meletios A. \|4 aut
773	0	8	\|i Enthalten in \|t Annals of hematology \|d Springer Berlin Heidelberg, 1955 \|g 100(2020), 1 vom: 27. Okt., Seite 297-302 \|h Online-Ressource \|w (DE-627)253389852 \|w (DE-600)1458429-3 \|w (DE-576)072283157 \|x 1432-0584 \|7 nnns
773	1	8	\|g volume:100 \|g year:2020 \|g number:1 \|g day:27 \|g month:10 \|g pages:297-302
856	4	0	\|u https://dx.doi.org/10.1007/s00277-020-04302-0 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_250
912			\|a GBV_ILN_267
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_711
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2132
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2433
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	r	v	\|a ELIB24
951			\|a AR
952			\|d 100 \|j 2020 \|e 1 \|b 27 \|c 10 \|h 297-302

Correction to: Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände